Patient P-02503
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
25%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 108 AD-05 recommended — Adherence Support AD-05
- Day 109 Patient declined — Not now
- Day 129 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 129.
Primary contributors, last 14 days
- Nutritional resilience-10
- GI instability-5
- Inflammatory activity-5
- Toxicity+3
What helped?
- Adherence Support AD-05Day 108Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable91 min
stable · -1.6 vs previous 14 d
Sleep duration
Wearable7 h
stable · +0.0 vs previous 14 d
Energy level
Daily log5.3/10
stable · -0.1 vs previous 14 d
Steps
Wearable9,122
stable · -120 vs previous 14 d
GI burden
Companion14/100
improving · -1.5 vs previous 14 d
Adherence
Companion83.2 %
stable · -3.0 vs previous 14 d
Sleep quality
Wearable58.3/100
stable · +0.7 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
stable · +1.8 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 74 from the failing basin, 53 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +10.8
- Butyrate producers intacthidden · steering +7.5
- Proteinsupporter · GI -5.9 next day
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Low-HRV stretchperturbation · steering -2.7
- Dietary driftperturbation · steering -2.6
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.9supporter · 95%
- Ultra-processed food+2.5no signal · 42%
- Caffeine-2no signal · 35%
- Insoluble fibre-1.3no signal · 25%
- Simple carbohydrates+0.9no signal · 15%
- Dietary fat load+0.7no signal · 15%
- Alcohol-0.5no signal · 15%
- Histamine load+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.9 · butyrate capacity 59/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 67 ms
- Sleep
- 6.9 h
- Steps
- 7,986
- Resting HR
- 62 bpm
Daily log: GI score 14, nutritional resilience 63, adherence 83.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02016 | 40% | S20 | DT-01 | improved | 27 |
| P-02331 | 40% | S14 | BR-03 | improved | 34 |
| P-02031 | 34% | S12 | AD-05 | improved | 47 |
| P-02479 | 33% | S13 | DT-01 | improved | 48 |
| P-02484 | 32% | S15 | GI-04 | improved | 49 |
| P-02494 | 32% | S09 | GI-04 | improved | 47 |
| P-02564 | 32% | S15 | BR-03 | improved | 32 |
| P-02638 | 31% | S01 | BR-03 | improved | 41 |
| P-02303 | 30% | S15 | GI-04 | improved | 48 |
| P-02339 | 30% | S03 | DT-01 | improved | 50 |
| P-02685 | 30% | S16 | DT-01 | improved | 47 |
| P-02223 | 29% | S20 | HY-01 | improved | 49 |